MEDICINOVA INC (MNOV)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.63+0.62%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MNOV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.4 | — | 1.0 | — | 4.0 | — | — | — | — | — | — | — | — | 0.8 | — |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.8 | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 5.1 | 6.7 | 6.8 | 5.3 | 8.7 | 8.1 | 7.1 | 5.7 | 5.3 | 3.9 | 3.1 | 2.7 | 2.9 | 2.7 | 4.5 | 7.8 |
| Operating Income | (11.9) | (13.3) | (12.7) | (9.9) | (14.6) | (10.2) | (14.2) | (14.0) | (15.6) | (13.0) | (10.9) | (8.8) | (9.2) | (4.0) | (10.9) | (16.1) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | 1.6 | 1.6 |
| EBT, Incl. Unusual Items | — | (12.0) | (11.0) | (8.6) | (14.1) | (10.1) | (13.9) | (12.9) | (14.7) | (12.9) | (10.9) | (8.8) | (9.2) | (4.0) | (11.0) | (17.7) |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (0.0) | 0.0 | 0.0 | (1.7) | 0.0 | 0.0 | (0.0) | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | 13.2 | (12.0) | (11.0) | 8.6 | (14.1) | (10.1) | (13.9) | (12.9) | (14.7) | (11.2) | (10.9) | (8.8) | (9.2) | (4.0) | (11.0) | (17.7) |
| Per Share | ||||||||||||||||
| Basic EPS | 0.27 | (0.24) | (0.23) | (0.17) | (0.29) | (0.21) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | 0.27 | (0.24) | (0.23) | (0.17) | (0.29) | (0.21) | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 49.2 | 49.1 | 49.0 | 49.0 | 49.0 | 48.6 | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 49.2 | 49.1 | 49.0 | 49.0 | 49.0 | 48.6 | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (13.3) | (12.7) | (9.9) | (14.6) | (10.2) | (14.2) | (14.0) | (15.6) | (13.0) | (10.9) | (8.8) | (9.2) | (3.9) | (10.9) | (16.1) |
| EBIT | (11.9) | (13.3) | (12.7) | (9.9) | (14.6) | (10.2) | (14.2) | (14.0) | (15.6) | (13.0) | (10.9) | (8.8) | (9.2) | (4.0) | (10.9) | (16.1) |
| Effective Tax Rate | — | — | — | -0.0% | -0.0% | -0.0% | 0.0% | -0.1% | -0.0% | 13.5% | -0.0% | -0.1% | 0.0% | -0.1% | -0.1% | -0.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.